CoChat

Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes

Wolever, TMS, Chiasson, J-L, Josse, RG, Hunt, JA, Palmason, C, Rodger, NW, Ross, SA, Ryan, EA, Tan, MH · 1997 · International Journal of Obesity

The DOI matches its Crossref record.

Abstract

Objectives To see if the long-term treatment of non-insulin dependent diabetes (NIDDM) with the alpha-glucosidase inhibitor acarbose affects food intake and body weight.Design Randomized, double-blind, placebo-controlled, parallel design clinical trial of 12 months duration.Subjects Subjects with NIDDM in four treatment strata: 77 on diet alone, 83 also treated with metformin, 103 also treated with sulfonylurea and 91 also treated with insulin.Measurements Two 3 day diet records were obtained before randomization to acarbose or placebo therapy, and additional 3 day diet records were obtained at 3, 6, 9 and 12 months after randomization. Body weight was also measured at these times.Results Of the 354 subjects randomized, 279 (79%) completed at least 9 months of therapy and, of these, 263 (94%) provided at least one diet record during the baseline period and two diet records during the treatment period. After one year, subjects on acarbose had lost 0.46 +/- 0.28 kg, which differed significantly from the 0.33 +/- 0.25 kg weight gain on placebo (P = 0.027). The difference in weight change between acarbose and placebo did not differ significantly in the different treatment strata. Being in the study had significant effects on diet, including a reduction in energy intake from 1760-1700 Kcal/d (P < 0.05), a reduction in simple sugars intake from 18.5-17.4% of energy (P < 0.001), and reductions in the number of different foods consumed (33-30, P < 0.001) and the number of meals eaten per day (4.7-4.3, P < 0.001). However, compared to placebo treatment, acarbose had no effect on energy intake, nutrient intakes, or dietary patterns.Conclusions In subjects with NIDDM on weight-maintaining diets, long-term acarbose therapy results in a small weight loss, but has no effect on energy or nutrient intakes. The weight loss induced by acarbose may be due partly to reduced doses of concomitant oral agents and insulin and partly to energy loss due to increased colonic fermentation.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ijo.0800468

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 71

Metadata

Authors
Wolever, T., Chiasson, J.-L., Josse, R., Hunt, J., Palmason, C., Rodger, N., Ross, S., Ryan, E., & Tan, M.
Affiliations
  • University of Toronto (CA)
  • Hôtel-Dieu de Montréal (CA)
  • St. Michael's Hospital (CA)
  • St Joseph's Health Care (CA)
  • University of Alberta (CA)
Venue
International Journal of Obesity
Published
1997-09
Volume
21
Issue
9
Pages
756-763
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W1975047618
Cited by
71
References
0
Citations by year
2023: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 1 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
2.14
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bayer Canada
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
acarbose, alpha-glucosidase inhibitors, type 2 diabetes, weight loss, body weight, energy intake, nutrient intake, dietary habits, dietary intake, metformin, sulfonylureas, insulin, dietary adherence, dietary diversity, meal frequency, monosaccharides, long-term drug therapy, placebo
MeSH terms
Energy Intake, Diabetes Mellitus, Type 2, Diet, Double-Blind Method, Drug Therapy, Combination, Eating, Enzyme Inhibitors, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Sulfonylurea Compounds, Time Factors, Trisaccharides, Cohort Studies, Weight Loss, Diet Records, Acarbose, Glycoside Hydrolase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes. https://app.cochat.ai/papers/10.1038/sj.ijo.0800468
The paper
Wolever, T., Chiasson, J.-L., Josse, R., Hunt, J., Palmason, C., Rodger, N., Ross, S., Ryan, E., & Tan, M. (1997). Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes. International Journal of Obesity. https://doi.org/10.1038/sj.ijo.0800468

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.